Ramipril pretreatment worsened renal injury and survival despite a reduction in renal inflammation in experimentally induced sepsis in mice
Introduction: The angiotensin converting enzyme inhibitor ramipril is a standard antihypertensive therapy for many patients. Because angiotensin II may promote inflammation, we were interested in whether basal pretreatment with ramipril may modify renal function and inflammation as well as systemic...
Main Authors: | Tzvetanka Bondeva, Katrin Schindler, Claudia Schindler, Gunter Wolf |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2020-05-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320320923977 |
Similar Items
-
Cloning of the Human <i>MORG1</i> Promoter: Differential Regulation by Hypoxia and Prolyl-Hydroxylase Inhibitors
by: Tzvetanka Bondeva, et al.
Published: (2022-02-01) -
The Role of Hypoxia on the Trimethylation of H3K27 in Podocytes
by: Johanna Barth, et al.
Published: (2023-09-01) -
Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Published: (2008) -
Worsening Pericardial Effusion Despite Intensive Hemodialysis
by: Rachel Royfman
Published: (2023-05-01) -
The effects of single and combined application of ramipril and losartan on renal structure and function in hypertensive rats
by: Lin Yun, et al.
Published: (2018-10-01)